SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 or 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
Report on Form 6-K dated July 16, 2002
Novartis AG
(Name of Registrant)
Lichtstrasse 35
4056 Basel
Switzerland
-------------------
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F.
Form 20-F X Form 40-F _
Indicate by check mark whether the registrant by furnishing the information
contained in this form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes _ No X
Enclosure: Reminder - Invitation for Telephone Conference, First Half 2002 Sales
& Results.
Investor Relations Novartis International AG
CH-4002 Basel
Switzerland
[LOGO] Karen J Huebscher, PH.D.
Tel +41 61 324 8433
Nafida Bendali
Tel +41 61 324 3514
Sabine Moravi, MBA
Tel + 41 61 324 8989
Fax + 41 61 324 8844
Silke Zentner
Tel + 41 61 324 8612
Francisco Bouzas
Tel + 41 61 324 2462
Fax + 41 61 324 8844
Internet Address:
http://www.novartis.com
REMINDER
- INVITATION FOR TELEPHONE CONFERENCE -
First Half 2002 Sales & Results
Dear Investor
We are pleased to invite you to our First Half Sales & Results 2002 conference
call. Please below the following dial-in numbers:
Date: Monday, July 22, 2002
Time: Advisable: dial-in 10 minutes before
06.00 p.m. Switzerland
05.00 p.m. UK
12.00 p.m. New York
Advisable: dial-in 10 minutes before
Phone numbers: +41 91 610 4111 or toll-free +800 2467 8700 Europe and ROW
+1 800 860 2442 US
You may access the conference call as a live audio webcast on the Internet on
July 22: http://www.novartis.com/investors (under upcoming event). This
information is now available for tests and for the submission of questions in
advance.
Additional financial information will be available on Monday, July 22, on the
Internet http://www.novartis.com/investors
Playback for 48 hours
Date: Monday, July 22, 2002
Time: 07.00 p.m. Switzerland
06.00 p.m. UK
01.00 p.m. New York
Phone numbers: +41 91 612 43 30 Europe and ROW
+1 877 344 7529 US
Code: 335 (followed by the # sign)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Novartis AG
Date: July 16, 2002 By: /s/ Malcolm B. Cheetham
Name: Malcolm B. Cheetham
Title: Head Group Financer
Group Fin. Reporting and Accounting